Alerts will be sent to your verified email
Verify Email
MONOPHARMA
|
Mono Pharmacare
|
Davin Sons Retail
|
Innovative Ideals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.94 % | 22.93 % | 5.91 % |
|
5yr average Equity Multiplier
|
3.7 | 2.0 | 4.57 |
|
5yr Average Asset Turnover Ratio
|
1.16 | 0.77 | 0.11 |
|
5yr Avg Net Profit Margin
|
2.14 % | 9.83 % | -311.17 % |
|
Price to Book
|
0.0 | 0.0 | 0.0 |
|
P/E
|
7.06 | 13.12 | 21.93 |
|
5yr Avg Cash Conversion Cycle
|
151.42 Days | 139.64 Days | 286.06 Days |
|
Inventory Days
|
219.92 Days | 60.96 Days | 2703.15 Days |
|
Days Receivable
|
79.66 Days | 124.65 Days | 275.67 Days |
|
Days Payable
|
54.73 Days | 65.05 Days | 263.73 Days |
|
5yr Average Interest Coverage Ratio
|
2.12 | 242.91 | -32.84 |
|
5yr Avg ROCE
|
11.4 % | 21.53 % | -24.66 % |
|
5yr Avg Operating Profit Margin
|
5.11 % | 13.51 % | -375.49 % |
|
5 yr average Debt to Equity
|
2.07 | 0.32 | 3.8 |
|
5yr CAGR Net Profit
|
34.58 % | n/a | n/a |
|
5yr Average Return on Assets
|
2.31 % | 9.89 % | -13.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.72 % | 63.18 % | 16.05 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 94.49 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -36.42 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mono Pharmacare
|
Davin Sons Retail
|
Innovative Ideals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|